Results 81 to 90 of about 5,217,497 (361)

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients

Translational Oncology, 2020
Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths.
Dolores Gallardo-Rincón, Rosa María Álvarez-Gómez, Edgar Montes-Servín, Alfredo Toledo-Leyva, Elizabeth Montes-Servín, David Michel-Tello, Gabriela Alamilla-García, Antonio Bahena-González, Elizabeth Hernández-Nava, Veronica Fragoso-Ontiveros, Raquel Espinosa-Romero, Lucely Cetina-Pérez   +11 more
doaj  

A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer

Nature Communications, 2019
Radiomics—the quantification of features within tumor images—has shown prognostic potential in cancer. Here, the authors use a machine learning approach to develop a radiomic-based small set of descriptors to predict ovarian cancer patient survival based
Haonan Lu, Mubarik Arshad, Andrew Thornton, Giacomo Avesani, Paula Cunnea, Ed Curry, Fahdi Kanavati, Jack Liang, Katherine Nixon, Sophie T. Williams, Mona Ali Hassan, David D. L. Bowtell, Hani Gabra, Christina Fotopoulou, Andrea Rockall, Eric O. Aboagye   +15 more
doaj   +1 more source

Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications

Journal of Ovarian Research, 2023
Background No residual disease (CC 0) following cytoreductive surgery is pivotal for the prognosis of women with advanced stage epithelial ovarian cancer (EOC).
Diederick de Jong, Amudha Thangavelu, Timothy Broadhead, Inga Chen, Dermot Burke, Richard Hutson, Racheal Johnson, Angelika Kaufmann, Peter Lodge, David Nugent, Aaron Quyn, Georgios Theophilou, Alexandros Laios   +12 more
doaj   +1 more source

An attention-based deep learning network for predicting Platinum resistance in ovarian cancer [PDF]

arXiv, 2023
Background: Ovarian cancer is among the three most frequent gynecologic cancers globally. High-grade serous ovarian cancer (HGSOC) is the most common and aggressive histological type. Guided treatment for HGSOC typically involves platinum-based combination chemotherapy, necessitating an assessment of whether the patient is platinum-resistant.
arxiv  

Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy

Frontiers in Cell and Developmental Biology, 2020
Ovarian cancer is one of the leading causes of death in patients with gynecological malignancy. Despite optimal cytoreductive surgery and platinum-based chemotherapy, ovarian cancer disseminates and relapses frequently, with poor prognosis.
Yanfei Yang, Yang Yang, Jing Yang, Xia Zhao, Xiawei Wei   +4 more
semanticscholar   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source

On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles [PDF]

, 2013
Dysregulated microRNA (miRNA) expression is a well-established feature of human cancer. However, the role of specific miRNAs in determining cancer outcomes remains unclear. Using Level 3 expression data from the Cancer Genome Atlas (TCGA), we identified 61 miRNAs that are associated with overall survival in 469 ovarian cancers profiled by microarray (p<
arxiv   +1 more source

Analysing spatial point patterns in digital pathology: immune cells in high-grade serous ovarian carcinomas [PDF]

arXiv, 2023
Multiplex immunofluorescence (mIF) imaging technology facilitates the study of the tumour microenvironment in cancer patients. Due to the capabilities of this emerging bioimaging technique, it is possible to statistically analyse, for example, the co-varying location and functions of multiple different types of immune cells.
arxiv  

Ovarian cancer in the world: epidemiology and risk factors

International Journal of Women's Health, 2019
Aim: Ovarian cancer is one of the most common gynecologic cancers that has the highest mortality rate. Considering the fact that knowledge on the incidence, mortality of ovarian cancer, as well as its risk factors is necessary for planning and preventing
Z. Momenimovahed, A. Tiznobaik, S. Taheri, H. Salehiniya   +3 more
semanticscholar   +1 more source